Adello Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Adello Biologics's estimated annual revenue is currently $4.2M per year.
- Adello Biologics's estimated revenue per employee is $201,000
Employee Data
- Adello Biologics has 21 Employees.
- Adello Biologics grew their employee count by -12% last year.
Adello Biologics's People
Name | Title | Email/Phone |
---|
Adello Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Adello Biologics?
Adello is a privately held, U.S.-based biotechnology company that leads with science to accelerate development and drive manufacturing efficiency. The company's aim is to provide high-quality, affordable biosimilars to patients worldwide. Headquartered in Piscataway, NJ and driven by a team of highly skilled industry veterans, Adello is advancing a strategic pipeline of proteins and complex monoclonal antibodies with lead candidates in oncology and immunology. For more information, visit Adellobio.com.
keywords:N/AN/A
Total Funding
21
Number of Employees
$4.2M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.8M | 21 | -51% | N/A |
#2 | $2.1M | 21 | -5% | N/A |
#3 | $3M | 21 | 5% | N/A |
#4 | $2.2M | 22 | 5% | N/A |
#5 | $3.7M | 22 | -12% | N/A |